November 21, 2018 – HealthMyne will be showcasing the Quantitative Imaging Decision Support (QIDS)® Platform in booth 7761 during the 2018 RSNA Meeting. Through interactive demos, attendees will experience how quantitative imaging data created at the Point-of-Read drives better patient management decisions at the Point-of-Care by reducing clinical variability.
As a fun way to introduce QIDS (pronounced /kwids/) to the RSNA audience, HealthMyne is inviting all attendees to come by and pronounce QIDS (/kwids/) correctly in order to enter a raffle for great prizes including two tickets to an American Cancer Society Gala with hotel and travel expenses. There are five $100 Amazon Gift Cards in the mix also. Everyone that enters also gets an instant prize. See a HealthMyne representative at booth 7761 for details.
Attendees can also perform a good deed while at RSNA just by taking part in a demo of the QIDS Platform at the HealthMyne booth. As they have for the past two years, for every demo, HealthMyne will be donating $25 to Gilda’s Club of Madison. Gilda's creates a community of free emotional support, cancer education, and hope for children and adults with any cancer diagnosis and those who care for them. Gilda’s – Madison sustained over $1 million in damages during historic storms that brought devastating flooding in August and is in desperate need of funds to get their facility repaired. HealthMyne hopes to double the number of demos and donations this year to help Gilda’s get open again.
“Our team is excited and ready to greet everyone at our brand-new booth located in the Machine Learning Showcase this year,” says Neal Miller, Vice President of Marketing at HealthMyne. “Every cancer patient’s story starts with an image, and their journey begins with caring professionals like those attending RSNA. If we can show them something new that can positively affect those patient’s outcomes while having some fun and helping Gilda’s at the same time, all the better.”
For more information on HealthMyne innovations, go to www.heathmyne.com
HealthMyne, Inc. (HM; Madison, WI) is focused on delivering Quantitative Imaging Decision Support (QIDS)® for Radiology and Oncology to U.S.-based multi-hospital systems with expansion to non-U.S. markets and other clinical specialties over time. The company’s FDA-cleared software platform's novel Rapid Precise Metrics (RPM)™ algorithms deliver Point-of-Read image-derived curated metrics integrated with other clinical systems data (e.g. PACS, EMR, RT) into multiple Point-of-Care workflow modules (Cancer Screening, Tumor Conference, Therapy Response, Incidental Findings, Thoracic, others) to ensure timely clinical decision support (CDS) and precise patient management. The QIDS platform provides actionable, patient-centric reports and an integrated clinical and imaging dashboard (PatientCare Timeline®) to optimize collaboration among the multidisciplinary care team. Additionally, the platform’s discoverable database supports data mining and AI-based application development for Precision Medicine/Big Data initiatives and for innovative clinical, translational, and commercial research by both medical centers and pharmaceutical/biotech companies.
Neal Miller, Vice President of Marketing
(608) 833-2610 x267